Apimeds Pharmaceuticals US, Inc.
Public company- Headquarters
- MATAWAN, New Jersey
- Ticker
- APUS
- CIK
- 0001894525
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOErick Frim | Oct 1, 2026 | Departed |
| CFOEric Sherb | Oct 1, 2026 | Appointed |
| member of the BoardSungjoon Chae | Sep 11, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- Executive departure
CFO departs: Erick Frim
Erick Frim, Interim Chief Financial Officer of Apimeds Pharmaceuticals US, Inc., resigns the role, effective September 29, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 1, 2026Role: Interim Chief Financial Officer
- Executive appointment
CFO appointed: Eric Sherb
Eric Sherb was named Chief Financial Officer of Apimeds Pharmaceuticals US, Inc., effective October 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 1, 2026Role: Chief Financial Officer
- Executive appointment
member of the Board appointed: Sungjoon Chae
Sungjoon Chae was named member of the Board of Apimeds Pharmaceuticals US, Inc., effective September 10, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: member of the Board
Last verified Nov 8, 2026